Establishment Labs Holdings Inc (ESTA) Stock Analysis: A 33% Upside in the Healthcare SectorEstablishment Labs Holdings Inc. (NASDAQ: ESTA) is capturing attention in the healthcare sector with its innovative approach to medical devices, particularly in the realm of aesthetic and reconstructive plastic surgeries. Performance-wise, Establishment Labs showcases a robust revenue growth rate of 16.30%, a promising sign for a company in the expansion stage. The average target price of $55.44 suggests a substantial potential upside of 33.25%, making it an attractive prospect for growth-focused investors. Establishment Labs does not currently pay a dividend, which fits its growth-oriented strategy, retaining all earnings to fuel further expansion. For investors seeking exposure to the healthcare sector, particularly in the medical device industry, Establishment Labs Holdings Inc. presents a compelling case.